Back
ProShares Ultra Russell2000 Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
72
UWM
ProShares Ultra Russell2000
Last Price:
48.94
Seasonality Move:
6.67%
Sell
47
APLS
Apellis Pharmaceuticals
Last Price:
29.28
Seasonality Move:
20.78%
Buy
72
ProShares Ultra Russell2000 (UWM)
is a Buy
Is ProShares Ultra Russell2000 a Buy, Sell or Hold?
- The current ProShares Ultra Russell2000 [UWM] share price is $48.91. The Score for UWM is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- UWM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UWM Stock Price Chart
What is ProShares Ultra Russell2000's stock price today?
-
The ProShares Ultra Russell2000 share price today is $48.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UWM is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $29.26
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
UWM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 65.72 | Buy |
| Chaikin Money Flow: | -502928 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.45 - 46.91) | Buy |
| Bollinger Bands (100): | (38.38 - 44.56) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 52.74 | Buy |
| Chaikin Money Flow: | 179519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.95 - 28.71) | Buy |
| Bollinger Bands (100): | (29.49 - 39.35) | Sell |
UWM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.78 | Buy |
| 20-day SMA: | 44.57 | Buy |
| 50-day SMA: | 42.73 | Buy |
| 200-day SMA: | 39.49 | Buy |
| 8-day EMA: | 47.46 | Buy |
| 20-day EMA: | 45.26 | Buy |
| 50-day EMA: | 43.36 | Buy |
| 200-day EMA: | 39.77 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.88 | Buy |
| 20-day SMA: | 28.02 | Buy |
| 50-day SMA: | 30.86 | Sell |
| 200-day SMA: | 43.85 | Sell |
| 8-day EMA: | 28.92 | Buy |
| 20-day EMA: | 28.61 | Buy |
| 50-day EMA: | 30.58 | Sell |
| 200-day EMA: | 40.41 | Sell |
ProShares Ultra Russell2000 Earnings Growth & UWM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
ProShares Ultra Russell2000 Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||